Literature DB >> 2004851

Benign breast disease and breast cancer: a case-control study in a cohort in Italy.

D Palli1, M Rosselli del Turco, R Simoncini, S Bianchi.   

Abstract

Sixty-two cases of invasive breast cancer were identified in a large cohort of women previously treated for biopsy-proven benign breast disease (BBD) at the Breast Unit of CSPO, in Florence, along with a group of 315 controls, strictly matched by age and year of diagnosis. A pathologist reviewed and reclassified all the original BBD slides according to recently proposed criteria (no evidence of epithelial proliferation, epithelial proliferation without or with atypia). Information about potential confounding factors was collected during personal interviews. In comparison to the women with "non-proliferative" BBD, women classified as having "proliferative disease without atypia" showed a weak and non-significant increase in risk (OR 1.3; 95% CI: 0.5-3.5). In contrast, women with "atypical hyperplasia" were at very high risk of developing breast cancer (OR 13.0; 95% CI: 4.1-41.7). When planning mammography screening or other large-scale early-diagnosis programmes for breast cancer in the general female population, follow-up of high-risk subgroups of BBD patients should be considered.

Entities:  

Mesh:

Year:  1991        PMID: 2004851     DOI: 10.1002/ijc.2910470513

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  16 in total

1.  Atypical hyperplasia and breast cancer risk: a critique.

Authors:  L Ma; N F Boyd
Journal:  Cancer Causes Control       Date:  1992-11       Impact factor: 2.506

2.  A multistage association study identifies a breast cancer genetic locus at NCOA7.

Authors:  Kathryn S P Higginbotham; Joan P Breyer; Kevin M Bradley; Peggy A Schuyler; W Dale Plummer; Marcia E Freudenthal; Amy Trentham-Dietz; Polly A Newcomb; Melinda E Sanders; David L Page; Fritz F Parl; Kathleen M Egan; William D Dupont; Jeffrey R Smith
Journal:  Cancer Res       Date:  2011-05-24       Impact factor: 12.701

Review 3.  Biological features of premalignant disease in the human breast.

Authors:  D C Allred; S K Mohsin
Journal:  J Mammary Gland Biol Neoplasia       Date:  2000-10       Impact factor: 2.673

Review 4.  Anatomic indicators (histologic and cytologic) of increased breast cancer risk.

Authors:  D L Page; W D Dupont
Journal:  Breast Cancer Res Treat       Date:  1993-11       Impact factor: 4.872

5.  Protein phosphatase 2A subunit gene haplotypes and proliferative breast disease modify breast cancer risk.

Authors:  William D Dupont; Joan P Breyer; Kevin M Bradley; Peggy A Schuyler; W Dale Plummer; Melinda E Sanders; David L Page; Jeffrey R Smith
Journal:  Cancer       Date:  2010-01-01       Impact factor: 6.860

Review 6.  Immunohistochemical studies of early breast cancer evolution.

Authors:  D C Allred; P O'Connell; S A Fuqua; C K Osborne
Journal:  Breast Cancer Res Treat       Date:  1994       Impact factor: 4.872

7.  Breast cancer risk by extent and type of atypical hyperplasia: An update from the Nurses' Health Studies.

Authors:  Laura C Collins; Sarah A Aroner; James L Connolly; Graham A Colditz; Stuart J Schnitt; Rulla M Tamimi
Journal:  Cancer       Date:  2015-11-13       Impact factor: 6.860

8.  Epidermal growth factor content of breast cyst fluids from women with breast cancer or proliferative disease of the breast.

Authors:  R Torrisi; S Zanardi; F Pensa; G Valenti; V De Franchis; G Nicolo; A Barreca; F Minuto; F Boccardo
Journal:  Breast Cancer Res Treat       Date:  1995-03       Impact factor: 4.872

9.  The utility of ductal lavage in breast cancer detection and risk assessment.

Authors:  Susan M Domchek
Journal:  Breast Cancer Res       Date:  2002-02-01       Impact factor: 6.466

10.  Epithelial atypia in biopsies performed for microcalcifications. practical considerations about 2,833 serially sectioned surgical biopsies with a long follow-up.

Authors:  Isabelle de Mascarel; Gaëtan MacGrogan; Simone Mathoulin-Pélissier; Anne Vincent-Salomon; Isabelle Soubeyran; Véronique Picot; Jean-Michel Coindre; Louis Mauriac
Journal:  Virchows Arch       Date:  2007-06-06       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.